Home » earnings reports » Johnson & Johnson (JNJ) earning estimates reports april 17 2012

Friday, April 13, 2012

Johnson & Johnson (JNJ) earning estimates reports april 17 2012

Johnson & Johnson (JNJ) earning estimates reports april 17 2012, jnj earning forecast march 2012, jnj q1earning prediction ; Johnson & Johnson (JNJ) reports its first quarter earnings on Tuesday, April 17, 2012.

What to Expect:
The consensus estimate is $1.36 per share, up 0.7% from a year ago when Johnson & Johnson reported earnings of $1.35 per share. Over the past three months, the consensus estimate has increased from $1.33. For the fiscal year, analysts are projecting earnings of $5.10 per share.

Revenue is projected to be $16.27 billion for the quarter, 0.6% above the year-earlier total of $16.17 billion. For the year, revenue is expected to come in at $66.4 billion.

Trends to Watch For:

Analyst Ratings:
The majority of analysts (52.2%) rate Johnson & Johnson as a buy. This compares favorably to the analyst ratings of its nearest 10 competitors, which average 50.6% buys. Analysts have grown increasingly optimistic about the stock in the last three months.

Competitors:
Johnson & Johnson is engaged in the research and development, manufacture, and sale of a range of products in the health care field. One of Johnson & Johnson’s main competitors in the pharmaceuticals industry, Pfizer (PFE), will report earnings on May 1, 2012. Other competitors in the healthcare sector include: Merck & Co (MRK), Abbott Laboratories Com Stk NPV (ABT), and Eli Lilly & Co (LLY).

Recent Price Movement:
The stock price has fallen slightly over the past quarter, from $64.69 on January 13, 2012 to its current price, $64.13.

Earnings estimates provided by Zacks.
For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post:

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)